Giant Axonal Neuropathy (GAN) Market is driven by Gene Therapy...

added blog Other

2025-05-02 07:41:54 -

Giant Axonal Neuropathy (GAN) Market is driven by Gene Therapy Advancements

Giant Axonal Neuropathy (GAN) is a rare, inherited neurodegenerative disorder characterized by progressive nerve damage due to mutations in the GAN gene, leading to impaired intracellular transport within neurons. GAN market offerings primarily comprise gene replacement therapies, viral vectors, and small-molecule modulators designed to correct or compensate for the defective gigaxonin protein....

0 Comments 0 Shares 784 Views 0 Reviews